EIC Pathfinder Open

EIC Pathfinder Open funds visionary, high-risk research into the science behind future breakthrough technologies. It is one of the few schemes in Europe genuinely willing to back work that has no product, no market, and not yet any proof it can work. There are no predefined topics, so any radical idea is welcome, and it targets the earliest stages of research, roughly TRL 1 to 4, where the real question is whether a technology is even possible. The offer is a pure grant of up to €4 million per project (raised from €3 million in the 2026 Work Programme), covering 100% of eligible costs with no equity and no repayment. The default route is a consortium of at least 3 independent entities from 3 different EU or Associated Countries, though a single entity can apply. The 2026 call had a budget of €166 million and attracted a record 2,103 proposals before closing on 12 May 2026; evaluation results are expected around October 2026. The next annual call is expected in early 2027, though exact dates have not yet been published. What it funds is concrete, not abstract. Companies and teams like CEREBRIS, working on multi-agent AI for neurological disease, HeartVision, opening new paths in heart failure therapy, and EUROPA, a laser-driven accelerator for medical radioisotopes, all took this route. Winners can later move toward market through EIC Transition and Accelerator.

• 100% funding rate — no co-financing needed
• No predefined topics — open to any breakthrough technology
• Up to €4M per project
• Duration: up to 4 years
• Access to EIC Programme Managers and transition support

Pathfinder Open is for research teams chasing a genuine scientific breakthrough that has no product, no market, and no proof it even works yet. If you are a university group, a deep-tech spin-off, or a research-heavy startup sitting at TRL 1 to 4 with a high-risk idea that could change a field, this is one of the only schemes in Europe that will fund you at 100% with no equity and no repayment. It is built for multidisciplinary consortia, so it fits best when your idea genuinely needs several disciplines and several countries to make it work. You should honestly skip it if you already have a working prototype, paying customers, or a clear route to market. That is Transition or Accelerator territory, and Pathfinder evaluators will mark you down for being too far along. Skip it too if you cannot assemble a credible 3-partner, 3-country consortium and have no path to single-entity justification, if your work is incremental rather than radical, or if you cannot wait roughly 8 months for a decision against single-digit odds.